ESC 365 - Effect of myocardial bridging on preoperative atrial fibrillation and survival in patients with obstructive hypertrophic cardiomyopathy

Open Access

Effect of myocardial bridging on preoperative atrial fibrillation and survival in patients with obstructive hypertrophic cardiomyopathy

Session: Hypertrophic cardiomyopathy: diagnosis and management

Topic: Epidemiology, Prognosis, Outcome

Speaker: Doctor C. Nie (Beijing, CN)

Event: ESC Preventive Cardiology 2024

Congress Presentation

Add to my library

About the speaker

Doctor Changrong Nie

Fuwai Hospital Chinese Academy of Medical Sciences, Beijing (China)

0 follower

10 more presentations in this session

Angiotensin II receptor blockers is associated a decreased left ventricular fibrosis in patients with obstructive hypertrophic cardiomyopathy

Speaker: Doctor C. Nie (Beijing, CN)

Are patients with hypertrophic cardiomyopathy given appropriate advice on exercise at a central London inherited cardiac conditions outpatient service?

Speaker: Doctor K. Sonthikaew (London, GB)

Cardiac magnetic resonance imaging aids in differentiating dilated cardiomyopathy from the athlete's heart

Speaker: Mr J. Daems (Utrecht, NL)

Optimising screening of intermediate to high-risk asymptomatic sportsmen with exercise electrocardiogram.

Speaker: Doctor D. Hupin (Saint-Etienne, FR)

Cardiopulmonary exercise testing in athletes and non-athletes with hypertrophic cardiomyopathy

Speaker: Doctor J. Scicluna (Msida, MT)

Access the full session

Hypertrophic cardiomyopathy: diagnosis and management

Speakers: Doctor C. Nie, Doctor C. Nie, Doctor K. Sonthikaew, Mr J. Daems, Doctor D. Hupin...

About the event

ESC Preventive Cardiology 2024

25 April - 27 April 2024

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources